How can pharmaceutical companies scale capacity faster across complex global markets?

Pharmaceutical companies today face rapid change: expanding manufacturing needs, reshoring strategies and increasing pressure to deliver complex facilities at speed. Navigating this landscape demands partners with both global reach and local expertise.  

Maurice Gillen, senior vice president and general manager for Jacobs’ Life Sciences business in Europe, supports organizations to meet these challenges by guiding large, multidisciplinary teams across a broad geographic footprint. 

Jacobs is one of the largest global service providers to the life sciences industry, with a strong presence across North America, Europe and Asia. This scale allows Maurice and his teams to deliver predictably anywhere in the world, across every major modality and at any project size.    

Across the industry, he sees capacity as the most pressing global challenge, ensuring organizations have the people, capabilities and digital solutions needed to meet accelerating demand. In Europe, the complexity of delivering across multiple jurisdictions, languages and regulatory environments requires deep local knowledge combined with the ability to leverage global expertise.  

For Maurice, the motivation behind this work is clear: the projects his teams deliver often enable cancer treatments, diabetes therapies and novel modalities that change how patients experience care. Beyond the mission, he enjoys bringing together teams across countries and disciplines, creating coalitions that can achieve outcomes no individual could accomplish alone.